Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis


Single dose of Poulvac IBMM+Ark protects long-lived broilers for at least 9 weeks

One dose of the live, attenuated vaccine Poulvac® IBMM+Ark effectively protected broilers against two infectious bronchitis (IB) strains for at least 9 weeks, a recent study shows.1

The vaccine is intended for use in chickens to protect against Massachusetts-type and 793B-type IB strains. Although its efficacy has been well demonstrated, researchers wanted to determine whether the vaccine’s duration of immunity met the needs of broiler breeds with longer lifespans, Luuk Stooker, DVM, a technical manager for Zoetis, said at the WVPA conference. In a study with specific-pathogen-free (SPF) chickens, researchers at the Animal Health Service, Deventer, the Netherlands, vaccinated birds with a single dose of Poulvac IBMM+Ark.

At 9 weeks of age, they challenged 20 of the vaccinated and 20 of the unvaccinated birds with M41, a Massachusetts IB strain; they also challenged another 20 vaccinated and 20 unvaccinated birds with the variant IB strain 793B, which is from the same serotype as the Arkansas IB strain. The results were compared to unvaccinated controls.

Five days after challenge, the ciliostasis test demonstrated that 95% of the vaccinated chickens were protected against the IB M41 challenge while 100% of the unvaccinated birds were affected. Among birds challenged with 793B, 90% of the vaccinated birds were protected and 75% of the unvaccinated birds were affected by 5 days after challenge.

“The results clearly demonstrate that a single dose of Poulvac IBMM+Ark effectively protected SPF chickens for at least 9 weeks after vaccination,” Stooker said.

1 Geerligs H, Stooker L, et al. Efficacy of a live infectious bronchitis vaccine containing the strains IBMM and ARK in SPF-chickens nine weeks after vaccination. 2013 world Veterinary Poultry Association Conference, Nantes, France. Zoetis inc. study #9118C- 50-11-009.


Posted on January 15, 2014

tags: , ,
  • Novel technologies needed to combat IB in chickens

    Despite decades of vaccination, the world poultry industry’s ongoing battle with infectious bronchitis (IB) continues to rage and points to the need for novel technologies to combat the disease.

  • E. coli vaccination helps contain losses in broilers with IB infection

    Field experience with infectious bronchitis in broilers during a harsh winter demonstrated that vaccination for secondary Escherichia coli infection helped stem losses

  • Consistency, follow-up key to controlling IBV

    Infectious bronchitis virus (IBV) is a “moving target” and trying to keep ahead of it requires consistency and follow-up, explained Sjaak de Wit, DVM, PhD, of GD Animal Health, the Netherlands.

  • Why infectious bronchitis is so resilient — and what broiler companies can do about it

    Control of infectious bronchitis (IB) requires good biosecurity, good management and rigorous administration of a vaccine that matches the circulating virus as closely as possible, John Smith, DVM, MAM, Alectryon LLC, formerly with Fieldale Farms, told Poultry Health...

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.